|Bid||162.00 x 200|
|Ask||220.00 x 100|
|Day's Range||171.61 - 174.63|
|52 Week Range||168.58 - 262.71|
|PE Ratio (TTM)||17.64|
|Dividend & Yield||5.12 (2.95%)|
|1y Target Est||N/A|
Mylan N.V. is best known for producing EpiPen emergency allergy treatments and generic drugs. Since 2011, Mylan has bought 99 percent stakes in five companies across the U.S. that own plants which process coal to reduce smog-causing emissions. Mylan is one of only a few public companies, and the only publicly-traded pharmaceutical maker, that uses these tax credits, a Reuters review of a comprehensive database of filings with the U.S. Securities and Exchange Commission found.
Shares of Target Corporation, ExxonMobil, and W.W. Grainger are well off of their highs lately. Perhaps it's time to take a closer look.
The DePaul University board of trustees has elected James T. Ryan as its new chairman. Ryan, who is chairman of Lake Forest, Illinois-based industrial supply company W.W. Grainger, succeeds William E. Bennett, who will continue to serve on the board. Ryan has been a member of DePaul's board of trustees since 2007.